ProtAffin Biotechnologie AG
1 clinical trials · Sponsor
◉ Watch ProtAffin Biotechnologie AG
| Record | Firm | Date |
|---|---|---|
| A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401 (NCT01627002) | ProtAffin Biotechnologie AG | 2012-05-01 |
Track ProtAffin Biotechnologie AG automatically
Every clearance here is in the API, with alerts when new ones post.